Improving long-term benefits for depression and anxiety (CO-IMPROVE)
Research type
Research Study
Full title
Co-developing Improving Access to Psychological Therapies (IAPT) services to improve long-term benefits for patients with depression and anxiety (CO-IMPROVE)
IRAS ID
323641
Contact name
Cintia Faija
Contact email
Sponsor organisation
The University of Manchester
Duration of Study in the UK
1 years, 2 months, 1 days
Research summary
Why? Research conducted in NHS Improving Access to Psychological Therapy (IAPT) services found that 53% of patients successfully completing low intensity psychological interventions for depression and/or anxiety experienced relapse within one year following treatment, with the vast majority doing so within 2 to 6 months.
What? Our research aims to understand what may facilitate/interfere with maintaining treatment gains following treatment and may help to prevent relapse to improve long-term benefits for IAPT patients following their care.
Who? We will be inviting patient, practitioners, and key informants (e.g., clinical academics, national leads) to take part in this research.
-Patients: aged 18 or over, that have received low intensity treatment for anxiety/depression in IAPT services in the last 6 months and met IAPT criteria for recovery at discharge.
-Practitioners/key informants: trainees/qualified practitioners delivering low intensity interventions in IAPT, IAPT Service Leads/Managers, IAPT Trainers, Clinical Academics, Policy Makers, National Leads and other IAPT stakeholders.
Where? Patients and practitioners from IAPT services located in Northern England delivering low intensity interventions. Other key informants/stakeholders from any IAPT services.
How? The research project will be conducted in three phases over 18 months. The involvement per phase is described below:
All participants interested in taking part will be asked to complete a consent form and a few questionnaires (15 minutes).
-Phase 1: Interviews with IAPT patients and practitioners/key informants (up to 1 hour). Maximum total time involvement: 1 hour 15 minutes.
-Phase 2: Group workshop/meeting (up to 5 hours) to co-produce a transdiagnostic relapse prevention toolkit for IAPT. Maximum total time involvement: 5 hours 15 minutes.
-Phase 3: Group meeting (up to 3 hours) to review and finalise the transdiagnostic relapse prevention toolkit developed in Phase 2. Maximum of total time involvement: 3 hours 15 minutes.
This research project is funded by the NIHR RfPB.
REC name
North West - Greater Manchester West Research Ethics Committee
REC reference
23/NW/0109
Date of REC Opinion
11 May 2023
REC opinion
Further Information Favourable Opinion